---
title: 'Associate Director, Patient Marketing at Cogent Biosciences'
canonical: 'https://feeny.ai/job/associate-director-patient-marketing-cogent-biosciences-waltham-massachusetts-rfrx7rz2grmj'
type: 'job'
last_seen: '2026-09-16'
---

# Associate Director, Patient Marketing at Cogent Biosciences

- **Company:** Cogent Biosciences
- **Location:** Waltham Massachusetts, United States
- **Posted:** 2026-06-26
- **Last confirmed live:** 2026-09-16
- **Apply:** https://job-boards.greenhouse.io/cogentbiosciences/jobs/4299290009

## Job description

Who We Are:

Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.

The Role: Cogent Biosciences is seeking an Associated Director of Patient Marketing to design and deliver a best-in-class, end-to-end patient experience for the launch of Bezuclastinib in Systemic Mastocytosis & Gastrointestinal Stromal (GIST) Tumors. Reporting to the Sr. Director of Patient Marketing, this individual will help shape how patients are identified, educated, activated, and supported throughout their disease and treatment journey. Serving as the internal champion for the patient voice, the role translates complex clinical data into meaningful, patient-centric resources and drives high-impact media strategies to reach those in need. In close collaboration with HCP marketing and patient services, this leader will help ensure a seamless transition from awareness to access and ongoing support. The ideal candidate brings deep rare disease and/or oncology expertise and a strong foundation in patient-centric marketing.

Responsibilities:

-

## Responsibilities Patient Strategy

- Support the develop and execution of a comprehensive U.S. patient marketing strategy across the product lifecycle, including unbranded disease awareness and branded campaigns
- Maintain and continuously refine the patient journey by identifying new inflection points, emotional hurdles, and barriers to treatment through ongoing insights collection
- Support patient-focused market research, in collaboration with the market insights & patient advocacy teams, to ensure all brand messaging resonates with the lived experience of patients with systemic mastocytosis and GIST

Resource and Digital Ecosystem Development Lead the creation of patient-facing materials and partner closely with the HCP Marketing and Sales teams to ensure patient resources are effectively utilized by the field in the clinical setting

- Design and implement an integrated digital ecosystem (e.g., branded patient websites, paid search, social, CRM, programmatic) that supports education, engagement, activation, and treatment adherence
- Track foundational metrics/KPIs and optimize performance in real-time
- Develop and oversee data-driven omnichannel strategies for patients cross multiple disease states to ensure high-impact outreach and engagement, and a strong KPI-based evaluation and optimization
- Ensure omnichannel plans align with brand strategy and launch plans and support HCP teams with omnichannel needs
- Integrate innovations, including AI-enabled tools, to accelerate marketing outcomes

Leadership and Collaboration

- Lead the internal integration of patient insights across the organization, partnering with cross-functional teams to bridge the gap between clinical data and patient experience, ensuring a seamless and unified brand journey
- Partner with Patient Advocacy, Patient Services and Market Access teams to build messaging and support tools that address education, affordability, reimbursement, and treatment continuity
- Coordinate with the Patient Advocacy team to ensure brand strategies align with the broader goals of the Systemic Mastocytosis & GIST patient communities

Qualifications:

-

- Bachelor’s degree required; Advanced degree (e.g., PharmD, MBA) preferred
- Oncology and/or rare disease launch experience required
- 5+ years of experience in pharmaceutical, biotech, or healthcare marketing, with 2+ years of experience in patient marketing
- Proven success in digital patient marketing (web, social, SEO/SEM, CRM, and paid media strategy) and media planning and execution
- Deep understanding of the patient journey and emotional drivers of behavior in rare disease and/or oncology disease populations
- Experience collaborating with patient services (Patient Advocacy and PSP) to develop aligned messaging and support tools
- Demonstrated ability to thrive in a fast-paced biotech environment
- Travel required (up to 25%), including occasional weekends
- Location: Waltham, MA (surrounding areas) required

Knowledge And Skills

- Ability to build clear and differentiated patient-friendly messaging to convey clinical benefit
- Strong analytical and problem-solving skills, with the ability to leverage market research and performance data to inform decisions and optimize impact
- Demonstrated experience developing and executing omnichannel strategies across multiple audiences and touchpoints
- Strong project management and operational execution skills; able to manage multiple workstreams and launch-critical deadlines in a fast-paced environment
- Excellent communication, storytelling, and presentation skills—able to simplify complex clinical information for varied audiences
- Experience managing agencies/vendors, budgets, and complex project plans with strong operational rigor and attention to detail
- Strong understanding of MLR processes
- Strong cross-functional leadership skills, including the ability to influence without authority

Salary Range:

$195,000- $230,000 USD

Target Bonus:20%

Exact compensation will vary based on skills, experience, and location.

Our Locations

Waltham, MA: Our headquarters is located in the Greater Boston life sciences community, with an open, collaborative office environment designed to support teamwork and connection. Employees benefit from convenient on-site amenities, including free on-site parking and gym facilities in the building.

Boulder, CO: Our Boulder location is home to Cogent’s discovery research organization and a key scientific hub with strong leadership based on site. Situated in the greater Denver-Boulder biopharmaceutical corridor, this office plays a central role in advancing our discovery efforts and pipeline.

Our Offer To You

At Cogent Biosciences, we offer a competitive salary, bonus, and ongoing stock awards, alongside a benefits package that sets us apart. We cover 100% of medical, dental, and vision premiums for you and your family, and help reduce out-of-pocket costs by funding up to 75% of in-network deductibles. Our benefits also include a 401(k) match with immediate vesting, generous paid time off, 12 weeks of fully paid parental leave, paid family and medical leave for all employees regardless of location, and company-paid short-term disability coverage for up to 20 weeks. Additional perks like wellness programs, tuition reimbursement, and inclusive family-forming support help you thrive at work and beyond.

We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.

## About Cogent Biosciences

## Company Overview
- **One-liner**: Cogent Biosciences is a publicly traded biotechnology company developing precision therapies for genetically defined diseases, with its lead program bezuclastinib targeting KIT D816V mutations in systemic mastocytosis and gastrointestinal stromal tumors.
- **Entity Type**: Public (NASDAQ: COGT)
- **Headquarters**: Waltham, Massachusetts, United States (with additional office in Boulder, Colorado)
- **Founded**: 2014
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology research and therapeutics development
- **Target customers**: Patients with genetically defined diseases, healthcare providers, and pharmaceutical partners (B2B/B2C hybrid)
- **Mission**: “To discover, develop, and commercialize best-in-class therapies that have a dramatic impact for patients with genetically defined diseases” [cogentbio.com](https://www.cogentbio.com/)

## Products & Services
- **Bezuclastinib**: A selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation and other KIT exon 17 mutations. In late-stage clinical development for advanced systemic mastocytosis (AdvSM), non‑advanced SM, and advanced gastrointestinal stromal tumors (GIST). Positive registration‑directed trial results reported in 2025. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Novel JAK2 V617F inhibitor**: A potential best‑in‑class mutant‑selective JAK2 inhibitor currently in preclinical development, with data presented at the 2026 EHA Congress. [cogentbio.com](https://www.cogentbio.com/)
- **Additional pipeline programs**: Research‑stage targeted therapies addressing mutations in ErbB2, PI3Kα, KRAS, and JAK2. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Market Standing
- **Valuation/Market Cap**: USD $762.7 million (as of mid‑2026, based on LinkedIn data) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Key Metric**: Annual revenue of USD $7.9 million (likely from partnerships or grants); total funding to date ~USD $1.82 billion (including post‑IPO equity, debt, and Series A). [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Notable Investors/Partners**: Series A led by Atlas Venture and F‑Prime; post‑IPO equity rounds led by Commodore Capital (2024, $225M), Fairmount Funds Management (2020, $104.4M) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Growth Signals**: Headcount grew 27.6% year‑over‑year to 223 employees; monthly LinkedIn follower growth of 3.0% (+61.7% annually); positive late‑stage trial results in 2025; expanded pipeline with new preclinical assets. [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)

## Competitive Advantages
- **Selective targeting of KIT D816V**: Bezuclastinib is designed to selectively and potently inhibit the key driver mutation in systemic mastocytosis, potentially offering a better safety/tolerability profile than earlier multi‑kinase inhibitors.
- **Late‑stage momentum**: Registration‑directed trials (APEX pivotal trial) have reported clinically meaningful results, positioning the company for potential regulatory submissions and commercialization.
- **Broad pipeline beyond KIT**: Research into JAK2, KRAS, PI3Kα, and ErbB2 mutations diversifies the platform and reduces single‑asset risk.
- **Strong capital position**: Over $760M market cap and access to public equity markets provide financial runway for multiple programs.

## Strategic Focus
- **Advance bezuclastinib to market**: Continue regulatory interactions and preparation for potential FDA approval in AdvSM and GIST, while expanding into non‑advanced SM.
- **Build a portfolio of precision therapies**: Invest in early‑stage discovery (Boulder, CO) to generate novel molecules targeting validated oncogenic drivers.
- **Commercial readiness**: Hiring commercial leadership (Chief Commercial Officer, Market Access, Field Medical Affairs) indicates preparation for a future product launch. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Why Work Here
- **Culture**: Emphasizes collaboration, urgency, inquisitiveness, and ingenuity. Corporate values include “Patients are waiting” (urgency), “Learning excites us” (inquisitiveness), “Succeed Together” (trust), and “Navigate uncertainty” (ingenuity). [cogentbio.com](https://www.cogentbio.com/careers/)
- **Work model**: Hybrid/remote flexibility – many roles are listed as remote (e.g., Area Directors for Field Medical Affairs, Patient Educators), while research roles are onsite in Boulder, CO. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Growth and impact**: As a late‑stage clinical company with an expanding pipeline, employees have direct influence on programs that could change patient lives. Fast‑paced environment with high autonomy.

## Sources
1. [Cogent Biosciences Corporate Website](https://www.cogentbio.com/)
2. [Cogent Biosciences About Page](https://www.cogentbio.com/about/)
3. [Cogent Biosciences Careers Page](https://www.cogentbio.com/careers/)
4. [Cogent Biosciences Job Board (Greenhouse)](https://job-boards.greenhouse.io/cogentbiosciences)
5. [Cogent Biosciences LinkedIn Profile](https://www.linkedin.com/company/cogentbiosciences)

## Other roles at Cogent Biosciences

- [Research Associate, Pharmacology & Cell Biology](https://feeny.ai/job/research-associate-pharmacology-cell-biology-cogent-biosciences-boulder-colorado-6t4r2c47nb6t) — Boulder Colorado, United States
- [Associate Director, Translational Medicine](https://feeny.ai/job/associate-director-translational-medicine-cogent-biosciences-waltham-rj8yex8parvp) — Waltham Massachusetts, United States
- [Director, Corporate Counsel](https://feeny.ai/job/director-corporate-counsel-cogent-biosciences-waltham-massachusetts-re6398tj5cwt) — Waltham Massachusetts, United States
- [Associate Director, Clinical Operations](https://feeny.ai/job/associate-director-clinical-operations-cogent-biosciences-waltham-massachusetts-ae9494b3zdm7) — Waltham Massachusetts, United States
- [Senior Manager, Medical Information](https://feeny.ai/job/senior-manager-medical-information-cogent-biosciences-united-states-je8kfksdfe70) — United States
- [Senior Manager, Quality Control GMP](https://feeny.ai/job/senior-manager-quality-control-gmp-cogent-biosciences-united-states-wdgyhgjzbkmw) — United States
- [Director, Drug Substance Manufacturing & Development](https://feeny.ai/job/director-drug-substance-manufacturing-development-cogent-biosciences-united-3xsj3y1318p1) — United States
- [Senior Medical Science Liaison - Midwest (Detroit, Minneapolis, Central Plains)](https://feeny.ai/job/senior-medical-science-liaison-midwest-detroit-minneapolis-central-plains-6y8fsqpt0n2k) — United States
- [Principal Scientist, Computational Chemistry](https://feeny.ai/job/principal-scientist-computational-chemistry-cogent-biosciences-boulder-colorado-f1xwrgthyhmq) — Boulder Colorado, United States
- [Desktop and Field Sales Support Specialist](https://feeny.ai/job/desktop-and-field-sales-support-specialist-cogent-biosciences-waltham-m2sxf462656q) — Waltham Massachusetts, United States